Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
CA 2501523 A1 · Owner: Grant, Struan F. · Inventors: Thorleifsson, Gudmar; Grant, Struan F.; Gulcher, Jeffrey R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Association of Type II diabetes and a locus on chromosome 5 is disclosed. In particular, the gene KCh1P 1 within this locus is shown by linkage analysis to be a susceptibility gene for Type Il diabetes. Pathway targeting for drug delivery and diagnosis applications in identifying those who have Type lI diabetes or are at risk of developing Type Il diabetes in particular those , that are non-obese are described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 31, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 31, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 31, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.